Finance

Lists
540222:BOM
Laurus Labs Ltd
2 062,40 ₹
+0,17%
(+3,40) 1D
19 հոկ, 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 540222...
Open
2 064,00 ₹
High
2 087,00 ₹
Low
2 055,00 ₹
Mkt. cap
1,11 տրլն
Avg. vol.
88,05 հզր
Volume
29,90 հզր
Dividend
0,10%
Quarterly dividend
0,50 ₹
Ex-dividend date
08 մյս, 2026 թ.
P/E ratio
101,97
52-wk high
2 087,00 ₹
52-wk low
901,85 ₹
EPS
20,23 ₹
Shares outstanding
106,44 մլն
No. of employees
7 հզր
Open
2 064,00 ₹
High
2 087,00 ₹
Low
2 055,00 ₹
Mkt. cap
1,11 տրլն
Avg. vol.
88,05 հզր
Volume
29,90 հզր
Dividend
0,10%
Quarterly dividend
0,50 ₹
Ex-dividend date
08 մյս, 2026 թ.
P/E ratio
101,97
52-wk high
2 087,00 ₹
52-wk low
901,85 ₹
EPS
20,23 ₹
Shares outstanding
106,44 մլն
No. of employees
7 հզր
News stories
From web sources and news partners
Profile
Laurus Labs is an Indian multinational pharmaceutical and biotechnology company headquartered in Hyderabad. Its focus areas include active pharmaceutical ingredients, generic formulations, custom synthesis, biotechnology, veterinary APIs and agrochemicals. The company was founded in 2005 by Satyanarayana Chava. Laurus Labs has its eight manufacturing plants located at Visakhapatnam, Hyderabad and Bangalore. The manufacturing units have received one or more approvals from USFDA, WHO, NIP Hungary, KFDA, MHRA, TGA, and PMDA. The company operates through its subsidiaries in Europe and United States and also offers its services in contract research, clinical research and analytical research through its R&D centers. The R&D centres are based in Hyderabad, Visakhapatnam and United States. Wikipedia
About Laurus Labs Ltd
CEOSatyanarayana Chava
Employees7,06 հզր
Founded2005
Headquarters-
Sector-
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
16,53 մլրդ
17,78 մլրդ
18,12 մլրդ
20,26 մլրդ
Cost of goods sold
6,63 մլրդ
6,95 մլրդ
8,34 մլրդ
7,56 մլրդ
Cost of revenue
6,63 մլրդ
6,95 մլրդ
8,34 մլրդ
7,56 մլրդ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2,16 մլրդ
2,29 մլրդ
2,57 մլրդ
2,59 մլրդ
Operating expense
7,07 մլրդ
7,24 մլրդ
5,86 մլրդ
7,56 մլրդ
Total operating expenses
13,71 մլրդ
14,19 մլրդ
14,20 մլրդ
15,12 մլրդ
Operating income
2,83 մլրդ
3,60 մլրդ
3,92 մլրդ
5,14 մլրդ
Other non operating income
269,60 մլն
57,60 մլն
-330,90 մլն
91,80 մլն
EBT including unusual items
2,70 մլրդ
3,25 մլրդ
3,62 մլրդ
4,81 մլրդ
EBT excluding unusual items
2,70 մլրդ
3,25 մլրդ
3,62 մլրդ
4,81 մլրդ
Income tax expense
759,80 մլն
734,50 մլն
794,60 մլն
1,19 մլրդ
Effective tax rate
28,09%
22,58%
21,98%
24,79%
Other operating expenses
3,71 մլրդ
3,74 մլրդ
2,07 մլրդ
3,73 մլրդ
Net income
1,95 մլրդ
2,52 մլրդ
2,79 մլրդ
3,68 մլրդ
Net profit margin
11,79%
14,15%
15,41%
18,14%
Earnings per share
3,61
4,65
5,17
6,80
Interest and investment income
-
-
65,70 մլն
-
Interest expense
-400,00 մլն
-387,90 մլն
-307,60 մլն
-422,20 մլն
Net interest expenses
-400,00 մլն
-387,90 մլն
-241,90 մլն
-422,20 մլն
Depreciation and amortization charges
1,20 մլրդ
1,21 մլրդ
1,22 մլրդ
1,24 մլրդ
EBITDA
4,01 մլրդ
4,62 մլրդ
5,12 մլրդ
6,34 մլրդ
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google Apps